| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/24/1997 | WO1997018300A3 Murine model for human carcinoma |
| 07/24/1997 | WO1997015668A3 Methods and compositions comprising glut-2 and glut-2 chimeras |
| 07/24/1997 | WO1997014808A3 Herpesvirus vectors and their uses |
| 07/24/1997 | WO1997010258A3 Antibodies against epitopes, exposed on surfaces of cancer cells outside desmosomes, of desmosomal cadherines |
| 07/24/1997 | WO1997007198A3 Dna sequences and secreted proteins encoded thereby |
| 07/24/1997 | WO1997006176A3 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 07/24/1997 | WO1996017956A3 Method of detection of nucleic acids with a specific sequence composition |
| 07/24/1997 | CA2844461A1 Compositions for treating anemia |
| 07/24/1997 | CA2253382A1 Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules |
| 07/24/1997 | CA2248638A1 Methods and compositions for inhibiting hexokinase |
| 07/24/1997 | CA2246431A1 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | CA2246268A1 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | CA2243531A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | CA2243505A1 Obesity protein formulations |
| 07/24/1997 | CA2243470A1 Recombinant aav virion for expressing epo in a mammal |
| 07/24/1997 | CA2243446A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | CA2243300A1 Compositions and methods for modulating cell proliferation using growth factor-polysaccharide binding fusion proteins |
| 07/24/1997 | CA2243269A1 Transgenic maize with increased mannitol content |
| 07/24/1997 | CA2243268A1 Anthranilate synthase gene and use thereof |
| 07/24/1997 | CA2242567A1 Diagnostic test to determine the malignancy of smooth muscle tumors |
| 07/24/1997 | CA2242400A1 H2-m modified transgenic animals |
| 07/24/1997 | CA2242376A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | CA2241952A1 Cellular immunogens useful as cancer vaccines |
| 07/24/1997 | CA2234680A1 Product for inhibition of attachment of h. influenzae to human cells |
| 07/24/1997 | CA2214840A1 System for the expression of heterologous antigens as fusion proteins |
| 07/23/1997 | EP0785282A2 Diagnosing and prognosing disease using sequences of the presenilin-1 gene |
| 07/23/1997 | EP0785279A1 Methods and apparatus for preparing, amplifying and discriminating multiple analytes |
| 07/23/1997 | EP0785277A1 Probe for diagnosing infectious diseases |
| 07/23/1997 | EP0785275A2 Transformed yeast strains |
| 07/23/1997 | EP0785274A1 An artifical recombinant substrate (rAGG-1) and native aggrecan to study the proteolytic activity of 'Aggrecanase' in cell culture systems |
| 07/23/1997 | EP0785273A1 Paired basic amino acid converting enzyme and DNA sequence encoding it |
| 07/23/1997 | EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785270A1 Staphylococcus aureus Seryl-tRNA synthetase |
| 07/23/1997 | EP0785269A1 Histidyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785268A1 Staphylococcus aureus methionyl-tRNA synthetase |
| 07/23/1997 | EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785262A1 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785260A1 Alanyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785259A1 Asparaginyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase |
| 07/23/1997 | EP0785257A1 Cysteinyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785256A1 Staphylococcus aureus glycyl-tRNA synthetase |
| 07/23/1997 | EP0785255A2 Identification, purification and detection of WSBV (baculovirus associated with white spot syndrome) |
| 07/23/1997 | EP0785254A2 Phosphatidyl-ionsitol glycan class F (PIG-F), the cDNA encoding it and their use as medicament |
| 07/23/1997 | EP0785253A1 Dictyocaulus viviparus antigen for diagnosis of lungworm affection and for vaccination |
| 07/23/1997 | EP0785252A1 Antisense oligonucleotides against the alpha regulatory subunit of the cAMP dependent-protein kinase for treatment of cancer |
| 07/23/1997 | EP0785217A1 Method of immunoassay for human BPGM |
| 07/23/1997 | EP0784753A1 Axial flow valve system for linear compressor |
| 07/23/1997 | EP0784702A1 Diagnostic test using fc receptor |
| 07/23/1997 | EP0784701A1 Method and apparatus for performing amplification of nucleic acid on supports |
| 07/23/1997 | EP0784700A1 Micobacterial reporter strains and uses thereof |
| 07/23/1997 | EP0784695A1 Method for preparing nucleic acids for analysis and kits useful therefor |
| 07/23/1997 | EP0784693A1 Viral vectors and line for gene therapy |
| 07/23/1997 | EP0784692A1 Attenuated viruses and method of making the same |
| 07/23/1997 | EP0784691A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 07/23/1997 | EP0784690A1 Complementary adenoviral vector systems and cell lines |
| 07/23/1997 | EP0784689A1 Microorganisms as therapeutic delivery systems |
| 07/23/1997 | EP0784688A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 07/23/1997 | EP0784687A2 CLONING AND EXPRESSION OF cDNA FOR HUMAN DIHYDROPYRIMIDINE DEHYDROGENASE |
| 07/23/1997 | EP0784686A1 Herpes simplex virus glycoprotein d variants |
| 07/23/1997 | EP0784685A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 07/23/1997 | EP0784684A2 RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES |
| 07/23/1997 | EP0784683A1 Tie-2 ligands, methods of making and uses thereof |
| 07/23/1997 | EP0784682A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/23/1997 | EP0784681A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 07/23/1997 | EP0784680A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 07/23/1997 | EP0784679A1 Cancer treatment by expression of differentiation factor receptor |
| 07/23/1997 | EP0784678A1 Genes encoding signal recognition particle of aspergillus niger |
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
| 07/23/1997 | EP0784672A1 Human inositol monophosphatase h1 |
| 07/23/1997 | EP0784632A1 Process for extracting high-purity von willebrand factor |
| 07/23/1997 | EP0784631A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 07/23/1997 | EP0784630A1 Selective inhibition of internally initiated rna translation |
| 07/23/1997 | EP0784488A1 Use of neuregulins as modulators of cellular communication |
| 07/23/1997 | EP0784484A2 Method of treatment of human immunodeficiency virus (hiv) infection |
| 07/23/1997 | EP0784483A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/23/1997 | EP0784482A2 Methods for inhibiting antigen specific t cell responses |
| 07/23/1997 | EP0784479A1 Inhibition of human rotavirus infection |
| 07/23/1997 | EP0784478A1 Inhibition of endothelin-1 to reduce inflammatory processes |
| 07/23/1997 | EP0784425A1 Gene controlling floral development and apical dominance in plants |
| 07/23/1997 | EP0784424A1 Cytoplasmic male sterility system producing canola hybrids |
| 07/23/1997 | EP0784421A1 Pest trap plants and crop protection |
| 07/23/1997 | EP0675964B1 HUMAN CYCLOOXYGENASE-2cDNA AND ASSAY FOR EVALUATING INHIBITION OF CYCLOOXYGENASE-2 |
| 07/23/1997 | EP0662135B1 Alteration of polypeptides |
| 07/23/1997 | EP0654092A4 Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes. |
| 07/23/1997 | EP0649464B1 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/23/1997 | EP0643772B1 Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
| 07/23/1997 | EP0638174B1 Measles virus-specific antibody detection using recombinant measles proteins |
| 07/23/1997 | EP0637996B1 Microfabricated detection structures |
| 07/23/1997 | EP0586617B1 Anti-CD3 aglycosylated IgG Antibody |
| 07/23/1997 | EP0502968B1 Activatable fibrinolytic and anti-thrombotic proteins |
| 07/23/1997 | EP0481999B1 Preventing interference with affinity capture schemes |
| 07/23/1997 | EP0474846B1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides |
| 07/23/1997 | EP0451194B1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |